Latest Licensing News

Arovella Therapeutics has filed an IND application for its lead CAR-iNKT therapy ALA-101, selected a CRO for its upcoming phase 1 trial, and secured $19.4 million in cash to fund clinical progress and pipeline expansion.

Condor Energy Limited has advanced its offshore Peru portfolio with a new high-potential oil prospect and a strategic gas offtake agreement, positioning itself for future commercialisation in a promising basin.

Great Northern Minerals has reported promising initial antimony assay results from its newly acquired Catalyst Ridge Project and secured a patent option for advanced rare earth flotation technology from the University of Arizona.

Foresta Group Holdings has updated its share registry provider, extended its technology license with E3 Carbon, and deferred earthworks at its Kawerau project to Q3 2026, while maintaining a solid cash position.

Firebird Metals has advanced its manganese-rich battery materials with a patented energy-saving kiln and precursor cathode outperforming Chinese benchmarks, while planning an Australian Demonstration Plant to break into Western markets.

Estrella Resources has kicked off bulk sample extraction at its Ira Miri manganese project in Timor-Leste, aiming to produce up to 30,000 tonnes of high-grade ore for appraisal and export. This milestone sets the stage for deeper geological insights and stronger international partnerships.

Generation Development Group (ASX, GDG) has reported a robust December quarter, with Funds Under Management surging across its core divisions, driven by strategic partnerships and acquisitions.

Noronex Limited’s ongoing 7,000m drilling program at its Powerline Copper Project in Namibia reveals further copper-silver mineralisation, reinforcing its geological model and partnership with South32.

Amplitude Energy has reported record quarterly production and revenue for Q2 FY26, alongside a dramatic reduction in net debt and the commencement of drilling for its East Coast Supply Project.

eMetals Limited has confirmed and extended a significant gold-in-soil anomaly at its Busia Gold Project in Uganda, highlighting promising early exploration results within a highly prospective greenstone belt.

Algorae Pharmaceuticals has locked in a $3 million revolving debt facility with ScotPac, providing flexible, non-dilutive funding to accelerate its commercial operations across Australia and New Zealand.

AdAlta Limited has aligned its AdCella manufacturing strategy with new US FDA guidelines, made a significant milestone payment to Shanghai Cell Therapy Group, and secured an additional R&D tax rebate, marking key progress in its cellular immunotherapy pipeline.